Clinical Trial Update: A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms [Phase 3]

View source ↗

Summary

Phase 3 pilot trial update of Daytrana for children with autism co-morbid ADHD symptoms; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder

Drugs mentioned

• Daytrana (methylphenidate transdermal patch)

Snippet

Sponsor: University of Oklahoma | Conditions: Autism, Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-02-06